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Objective: To screen the effect of 28 medicinal plants on inhibition of pancreatic lipase
and evaluate the phytochemical contents of extracts.
Methods: The ethanolic extracts of 28 traditional Thai herbal medicines were assayed
for their in vitro activities against porcine pancreatic lipase using p-nitrophenyl butyrate
as a substrate. Quantitative estimation of ﬂavonoids, phenolics, and alkaloids was done.
Results: Extracts from four herbs, Memecylon edule Roxb., Garcinia vilersiana Pierre,
Cryptolepis elegans Wall. and Phyllanthus chamaepeuce Ridl., at a concentration of
100 mg/mL, strongly inhibited porcine pancreatic lipase by 90.97%, 92.04%, 94.64% and
95.38%, respectively. There was a signiﬁcant positive correlation between phenolic
content and inhibition activity. Inhibition activity was signiﬁcantly correlated with
ﬂavonoid and with alkaloid contents.
Conclusions: From this result, it could be concluded that herbs represent a rich of anti-
pancreatic lipase compounds, in particular, Cryptolepis elegans Wall. and Phyllanthus
chamaepeuce Ridl. It is suggested that the phytochemical compounds from these plants
may be applied for the prevention and treatment of obesity or hyperlipidemia.1. Introduction
Obesity is becoming a worldwide epidemic, resulting in a
major risk factor for coronary heart diseases including diabetes
mellitus, metabolic syndrome, stroke, and some cancers [1].
Globally, around 39% of adults aged 18 and over were
overweight in 2014 and 13% of them were clinically obese [2].
Therefore, prevention and treatment of obesity become an
important factor for a healthy condition. The reduction of
nutrient digestion and absorption by developing of enzyme
inhibitors without altering major mechanism in gastrointestinal
system became the most important strategies in the treatment
of obesity [3,4]. The major source of unwanted calories is
dietary lipids, therefore, lipid metabolism play a major role in
maintaining energy homeostasis [5]. The identiﬁcation andcharacterization of several enzymes involved in lipid
metabolism have yielded a rich pool of potential targets for
drugs to treat obesity and other metabolic disorders [6].
Pancreatic lipase is the key enzyme for dietary fat digestion
and absorption. Therefore, inhibition of this enzyme would be
in effect to reduce lipid absorption from intestine and lead to a
consequence suppress of weight gain. Orlistat, a speciﬁc drug
for inhibiting pancreatic lipase that reduces dietary fat
absorption by 30%, has been approved for clinical use [4,7,8].
However, Orlistat can result in adverse side effects, such as
fecal incontinence, ﬂatulence, and steatorrhea [9,10]. Therefore,
the investigation to ﬁnd new safety medication for anti-obesity
is still needed. The signiﬁcant progress of the development of
anti-obesity from medicinal plants has provided potential ther-
apeutic targets for obesity [11,12]. It has been recently reported
that natural compounds from plants and other organisms have
been approved as anti-pancreatic lipase activities. For example,
ethanolic extract from Terminalia paniculata bark [13],
polyphenols from Oolong tea [14], Abroma augusta extract
[15], pomegranate leaves ethanol extract [16], and other
components from other kinds of herbs. However, it remains
necessary to search for more effective lipase inhibitors from
traditional herbs. In this study, we investigated the ethanolican open access article under the CC BY-NC-ND
Table 1
Lipase inhibitory effects of 28 selected traditional Thai medicinal herbs. %.
Scientiﬁc name Family Inhibition
Artocarpus lakoocha Roxb. Moraceae 12.68 ± 1.10*
Azadirachta indica A. Juss. Meliaceae 34.85 ± 2.70*
Belamcanda chinensis (L.) DC. Iridaceae 6.58 ± 1.30*
Brucea javanica (L.) Merr. Simaroubaceae 22.83 ± 3.20*
Canarium subulatum Guill. Burseraceae −26.84 ± 1.70*
Canthium berberidifolium
Geddes
Rubiaceae −5.76 ± 0.70*
Congea siamensis Fletcher Verbenaceae 70.00 ± 1.30
Cratoxylum formosum (Jack)
Dyer T.
Guttiferaes 67.47 ± 1.30
C. elegans Asclepiadaceae 94.64 ± 1.10
Dillenia ovata Wall. Dilleniaceae 5.97 ± 0.60*
*
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activities against porcine pancreatic lipase using p-nitrophenyl
butyrate (p-NPB) as a substrate.
2. Materials and methods
2.1. Materials
Porcine pancreatic lipase, p-NPB, morpholinepropanesul-
phonic acid, quercetin, colchicine and gallic acid were purchased
from Sigma Aldrich. The fresh leaves of 28 plants were
collected from Plant Genetic Conservation Forest, Ubon
Ratchathani Rajabhat University, Ubonratchathani Province,
Thailand. All plant species were identiﬁed and authenticated by
Mr. Prakorb Boonma, Senior Plant Taxonomist, Ubon Ratch-
athani Rajabhat University, Thailand.
2.2. Preparation of plant extracts
The leaves were dried in hot air oven at 50 C for 48 h and
grounded into ﬁne powder. A total of 50 g powder was extracted
in 95% ethanol and concentrated at 55 C in a rotary vacuum
evaporator (Heidorf, Germany). The obtained extracts were
stored at −20 C until use.
2.3. Porcine pancreatic lipase inhibition assay
Lipase activity was measured using p-NPB as a substrate.
The method was modiﬁed from the previously described by Kim
et al. [17]. Brieﬂy, an enzyme buffer was prepared by the
addition 30 mL of solution of porcine pancreatic lipase
(2.5 mg/mL in 10 mmol/L morpholinepropanesulphonic acid
and 1 mmol/L ethylenediamine tetraacetic acid, pH 6.8) to
850 mL of Tris buffer (100 mmol/L Tris–HCl and 5 mmol/L
CaCl2, pH 7.0). Then, either 100 mL of the plant extracts
(100 mg/mL) or Orlistat was added and incubated for 15 min
at 37 C. Ten microliter of substrate (10 mmol/L p-NPB in
dimethyl formamide) was then added and incubated for
30 min at 37 C. Lipase activity was determined by measuring
the hydrolysis of p-NPB to p-nitrophenol at 405 nm using an
ELISA reader (Biochrome, England). The inhibitory activity
(I) was calculated according to the following formula:
I%=

1−
B− b
A− a

× 100
where A is the activity of the enzymewithout inhibitor, and a is the
negative control without inhibitor; B is the activity of the enzyme
with inhibitor, and b is the negative control with inhibitor.
2.4. The half maximal inhibitory concentration (IC50)
determination
The IC50 value of extracts was determined at a concentration
of 500.0, 250.0, 125.0, 100.0, 25.0, 12.5 and 5.0 mg/mL. Orlistat
was used as a positive control. IC50 value was calculated by the
following formula:Diospyros ﬁlipendula Pierre
ex Lecomte
Ebenaceae 59.15 ± 0.90
Eurycoma longifolia Jack Simaroubaceae 1.04 ± 1.20*
Ficus foveolata Wall. Moraceae 6.99 ± 1.30*
*IC50 = (50% − LowInh%)/(HighInh% − LowInh%) ×
(HighConc − LowConc) + LowConcformula:where LowInh%/HighInh% signify % inhibition directly
below/above 50% inhibition, and LowConc/HighConc are the
corresponding concentrations of extract.
2.5. Determination of total phenolic content
According to a previously described protocol [18], Folin–
Ciocalteu reagent was used to determine the total phenolic
content of extracts. Absorbance was measured at 725 nm. All
tests were performed 6 times. The phenolic content was
calculated based on a gallic acid standard curve.
2.6. Determination of total ﬂavonoid content
Total ﬂavonoid content was determined according to a pre-
viously discussed method [18] using quercetin as a standard. The
absorbance was measured at 510 nm. The ﬂavonoid content was
calculated based on a quercetin standard curve.
2.7. Quantiﬁcation of alkaloid content
Quantiﬁcation of alkaloid content for extracts was carried out
using a method described earlier [19]. The absorbance was taken
at 500 nm and all tests were performed 6 times. The alkaloid
content was evaluated based on the colchicine standard curve.
2.8. Statistical analysis
Statistical analysis of the data was performed using the SPSS
16.0 program. The comparison between Orlistat control and
extract group was conducted using the Mann–Whitney U test,
and the correlations between parameters were determined using
the Spearman's rank test.
3. Results
A total of 28 extracts were prepared from leaf part of the
traditional Thai medicinal herbal medicines and were tested at a
concentration of 100 mg/mL for porcine pancreatic lipase inhi-
bition (Table 1).Garcinia cowa Roxb. ex DC. Guttiferae 14.91 ± 2.40
(continued on next page)
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Figure 1. The half maximal inhibitory concentration (IC50) of selected
crude extracts.
*P < 0.05 compared to Orlistat, data were presented as mean ± SD (n = 3).
Table 1 (continued )
Scientiﬁc name Family Inhibition
G. vilersiana Guttiefrae 92.04 ± 1.10
Gomphia serrata (Gaertn.)
Kanis
Ochnaceae 30.18 ± 2.70*
Litchi chinensis Sonn. Sapindaceae 12.28 ± 0.40*
Memecylon edule Roxb. Melastomataceae 90.97 ± 0.30
Naringi crenulata (Roxb)
Nicolson ST.
Rutaceae −0.67 ± 1.20*
P. chamaepeuce Euphorbiaceae 95.38 ± 2.40
Phyllanthus gomphocarpus
Hook. f.
Euphorbiaceae −5.19 ± 2.10*
Prismatomeris sessiliﬂora
Pierre ex Pitard
Rubiaceae 80.11 ± 0.20
Quercus kingiana Craib Fagaceae −12.70 ± 1.10*
Salacia verrucosa Wight Celastraceae −6.09 ± 0.80*
Spatholobus harmandii Gagnep. Fabaceae 24.28 ± 0.60*
Syzygium gratum (Wight)
S.N. Mitra var. gratum
Myrtaceae −34.93 ± 2.40*
Tiliacora triandra (Colebr.)
Diels
Menispermaceae −19.47 ± 2.20*
Xantolis cambodiana (Pierre
ex Dubarb) P. Royen
Sapotaceae 87.55 ± 2.20
Orlistat 96.56 ± 0.20
* P < 0.05 compared to Orlistat, data were presented as mean ± SD
(n = 3). The ﬁnal concentration of the extracts used in this experiment was
100 mg/mL. G. vilersiana: Garcinia vilersiana Pierre; C. elegans: Cryp-
tolepis elegans Wall.; P. chamaepeuce: Phyllanthus chamaepeuce Ridl.
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activity of >50% against porcine pancreatic lipase: 59.15% with
Diospyros ﬁlipendula, 67.47% with Cratoxylum formosum,
70.00% with Congea siamensis, 80.11% with Prismatomeris
sessiliﬂora, 87.55% with Xantolis cambodiana, 90.97% with
Memecylon edule, 92.04% with G. vilersiana, 94.64% with C.
elegans, and 95.38% with P. chamaepeuce. The extracts of
Gomphia serrata andAzadirachta indica showed>30% inhibition
of pancreatic lipase. There were several herbs showed slightly
effect on inhibition against pancreatic lipase. Besides, some of
herbs increased in the activity of pancreatic lipase, such as Syzy-
gium gratum, which promoted the activity of enzyme by 34.93%.
The different concentration of crude extracts of G. vilersiana,
C. elegans, and P. chamaepeuce were measured for IC50 at a
concentration of 500.0, 250.0, 125.0, 100.0, 25.0, 12.5 and 5.0 mg/
mL. The extracts ofG. vilersiana, C. elegans and P. chamaepeuce
had IC50 values of 0.11, 0.30 and 0.45 mg/mL, respectively.
Whereas, Orlistat had IC50 value of 0.08 mg/mL (Figure 1).
The correlations between phytochemical content measured in
extracts and inhibition activity were shown in Figure 2. There1.0
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Figure 2. Correlation of phenolic, ﬂavonoid, and alkaloid contents with porci
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a total sample analyses were listed.was a signiﬁcant positive correlation between phenolic content
and inhibition activity. Inhibition activity was signiﬁcantly
correlated with ﬂavonoid and alkaloid contents.4. Discussion
Pancreatic lipase is a key enzyme for lipid absorption by
hydrolysis of total dietary fats. Therefore, inhibition of pancre-
atic lipase is suggested to be an effective therapy in the regu-
lation of obesity. Although Orlistat has anti-obesity effects by
inhibiting pancreatic lipase activity, however, it can cause
adverse side effects, such as fecal incontinence, ﬂatulence, and
steatorrhea [9,10]. Therefore, the investigation of new agent for
pancreatic lipase inhibitor is still needed. Our ﬁnding is the
ﬁrst time to show that crude extracts of G. vilersiana,
C. elegans and P. chamaepeuce exhibited strong anti-lipase
activity. This suggests that these herbs seem to be the poten-
tial candidates as the inhibitor of pancreatic lipase. However,
further in vivo studies on animal model must be conducted in
order to conﬁrm this hypothesis.
Our results showing a signiﬁcant positive correlation be-
tween phenolic, ﬂavonoid, alkaloid contents and inhibition ac-
tivity, which provide strong support that these phytochemical
compounds are key agents for pancreatic lipase inhibition. This
assumption is further supported by the previous results showing
that phenolic compounds exhibit the ability to inhibit pancreatic0.35
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ﬂavonoids and alkaloid be able to inhibit pancreatic lipase
[24,25]. The study in vivo model indicated that polyphenols and
ﬂavonoid glycoside derived from Salix matsudana leaf showed
decreased in body weight gain in Wistar rats [21]. According
to these reports, we hypothesized that these three compounds
may be the main contributors to the inhibition of pancreatic
lipase. Experimental proof for this assumption is now required.
Although high activities on pancreatic lipase inhibition were
detected in crude extracts of G. vilersiana, C. elegans and
P. chamaepeuce, the further investigation for both in vitro and
in vivo should be performed to elucidate the bioactive com-
pounds, to clarify the molecular mechanism and to verify the
main effective phytochemicals in these three candidates which
are responsible for the inhibition of pancreatic lipase activity.
For example, caffeine, chlorogenic acid, feruloylquinic acids
derived from Coffea canephora showed to inhibit pancreatic
lipase in vitro and decrease body weight gain of mice by 157%
[26]. It has been reported that crocetin derived from Gardenia
jasminoides showed inhibitory activity of pancreatic lipase
in vitro and 25% decreased in body weight gain of Triton
WR-1339-induced hyperlipidemia mice [27,28].
We concluded that phenolic, ﬂavonoid and alkaloid com-
pounds in G. vilersiana, C. elegans and P. chamaepeuce are key
agents for pancreatic lipase inhibition in vitro. These three plants
should be explored as dietary supplements or nutraceutical foods
with anti-obesity properties. To the best of our knowledge, the
puriﬁcation of active compounds of certain pancreatic lipase
inhibitor is under investigation.
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